Literature DB >> 24811241

Distinct pattern of hypometabolism and atrophy in preclinical and predementia Alzheimer's disease.

Vanja Kljajevic1, Michel Jan Grothe2, Michael Ewers3, Stefan Teipel4.   

Abstract

The goal of the present study was to determine the earliest patterns of hypometabolism and atrophy in the development of Alzheimer's disease (AD). Stages of AD were defined by positron emission tomography imaging evidence of cortical amyloid pathology in addition to cognitive criteria. Subjects for the study were selected from the Alzheimer's Disease Neuroimaging Initiative database and divided into 4 groups: cognitively normal (CN) amyloid negative (Aβ-) elderly subjects (n = 36), CN amyloid-positive (Aβ+) (n = 21), early mild cognitive impairment Aβ+ (n = 65), and late mild cognitive impairment Aβ+ (n = 23) subjects. Region of interest-based (primary) and voxel-based (secondary) analyses were used to assess gray matter hypometabolism, quantified by [18F]fluorodeoxyglucose-positron emission tomography, and decrease in gray matter volume and cortical thickness was measured by magnetic resonance imaging. Region of interest- and voxel-based analyses showed significant hypometabolism but not atrophy in CN Aβ+ subjects compared with CN Aβ- subjects. The results suggest that hypometabolism exceeds atrophy in preclinical AD, supporting the notion that amyloid load may affect synaptic activity, leading to synaptic loss and subsequent neuronal loss.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Amyloid; Imaging biomarkers; Mild cognitive impairment

Mesh:

Substances:

Year:  2014        PMID: 24811241     DOI: 10.1016/j.neurobiolaging.2014.04.006

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  22 in total

1.  Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment.

Authors:  Michel J Grothe; Helmut Heinsen; Edson Amaro; Lea T Grinberg; Stefan J Teipel
Journal:  Cereb Cortex       Date:  2015-04-02       Impact factor: 5.357

Review 2.  The relationship between atrophy and hypometabolism: is it regionally dependent in dementias?

Authors:  María C Rodriguez-Oroz; Belen Gago; Pedro Clavero; Manuel Delgado-Alvarado; David Garcia-Garcia; Haritz Jimenez-Urbieta
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

3.  Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load.

Authors:  Michel J Grothe; Sylvia Villeneuve; Martin Dyrba; David Bartrés-Faz; Miranka Wirth
Journal:  Neurology       Date:  2017-01-06       Impact factor: 9.910

Review 4.  Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2017-03-22       Impact factor: 21.566

5.  Differential effects of ischemic vascular disease and Alzheimer's disease on brain atrophy and cognition.

Authors:  Ling Zheng; Harry V Vinters; Wendy J Mack; Michael W Weiner; Helena C Chui
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

6.  Impact of plasma glucose level on the pattern of brain FDG uptake and the predictive power of FDG PET in mild cognitive impairment.

Authors:  Ivayla Apostolova; Catharina Lange; Per Suppa; Lothar Spies; Susanne Klutmann; Gerhard Adam; Michel J Grothe; Ralph Buchert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-03       Impact factor: 9.236

7.  Brain metabolic signatures across the Alzheimer's disease spectrum.

Authors:  Arianna Sala; Camilla Caprioglio; Roberto Santangelo; Emilia Giovanna Vanoli; Sandro Iannaccone; Giuseppe Magnani; Daniela Perani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-12-07       Impact factor: 9.236

Review 8.  Activation of the Brain to Postpone Dementia: A Concept Originating from Postmortem Human Brain Studies.

Authors:  Qiong-Bin Zhu; Ai-Min Bao; Dick Swaab
Journal:  Neurosci Bull       Date:  2019-02-05       Impact factor: 5.203

9.  Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau ΔK280.

Authors:  Frank J A Dennissen; Marta Anglada-Huguet; Astrid Sydow; Eckhard Mandelkow; Eva-Maria Mandelkow
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-26       Impact factor: 11.205

10.  Spatial patterns of atrophy, hypometabolism, and amyloid deposition in Alzheimer's disease correspond to dissociable functional brain networks.

Authors:  Michel J Grothe; Stefan J Teipel
Journal:  Hum Brain Mapp       Date:  2015-10-06       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.